Screener
Amgen AMGN Accrued sales incentives and allowance
Accrued sales incentives and allowance at other companies
Other financials
Where this comes from
Reported directly by Amgen in its filing.
Tagged under the XBRL concept amgn:IncreaseDecreaseInSalesIncentivesAndAllowance.
The source filing: Amgen’s 10-Q, filed August 5, 2026.
- Filed
- Aug 4, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000318154-26-000126
| Line item | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|
| Accrued income taxes, net | (60) | (2,313) |
| Long-term tax liabilities | 148 | 162 |
| Accrued liabilities | (58) | (50) |
| Accrued sales incentives and allowance | 278 | 1,113 |
| Other liabilities | (107) | (70) |
| Net cash provided by operating activities | 6,191 | 3,671 |
| Cash flows from investing activities: | ||
| Purchases of property, plant and equipment | (1,225) | (780) |
Item 1. FINANCIAL STATEMENTS
FAQ
- What is Amgen's accrued sales incentives and allowance?
- Amgen (AMGN) reported accrued sales incentives and allowance of $1.12B in Q2 2026.
- How has Amgen's accrued sales incentives and allowance changed year-over-year?
- Amgen's accrued sales incentives and allowance increased by 78.1% year-over-year, from $627M to $1.12B.
- What is the long-term trend for Amgen's accrued sales incentives and allowance?
- Over 3 years (2021 to 2024), Amgen's accrued sales incentives and allowance has grown at a 43.5% compound annual growth rate (CAGR), from $404M to $1.19B.
- What does accrued sales incentives and allowance mean?
- Accrued sales incentives and allowance as reported by Amgen Inc.
Ask your AI about Amgen's accrued sales incentives and allowance.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude